当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 资产负债表

华兰生物

(002007)

  

流通市值:258.09亿  总市值:299.92亿
流通股本:15.74亿   总股本:18.29亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金1,102,190,831.951,366,659,508.49843,155,746.522,026,889,197.5
应收票据及应收账款1,870,813,379.21,798,428,848.412,368,410,452.421,750,250,436.69
应收账款1,870,813,379.21,798,428,848.412,368,410,452.421,750,250,436.69
应收款项融资197,154,765.85253,783,518.89145,781,458.71211,103,745.79
预付款项91,106,230.9471,954,565.7568,099,249.1871,656,956.86
其他应收款合计19,375,503.9518,322,717.9816,568,395.2516,582,814.1
存货2,231,831,545.82,028,565,707.691,905,908,043.121,921,748,320.6
一年内到期的非流动资产2,384,265,798.62,143,615,395.822,049,849,472.231,333,004,000
其他流动资产106,091,894.2246,842,268.590,094,251.3760,064,447.62
流动资产平衡项目0000
流动资产合计10,549,823,747.899,616,191,068.199,266,229,186.629,017,925,039.32
非流动资产:
长期股权投资--6,034,995.112,990,540.74
固定资产2,404,631,459.22,401,604,027.32,039,752,564.372,080,861,919.15
在建工程563,982,791.49552,479,848.58792,268,823.88705,116,003.24
生产性生物资产531,685.26929,509.83856,329.92-
使用权资产8,975,971.839,119,267.079,262,562.339,405,857.57
无形资产316,138,918.75319,041,041.19315,925,342.79318,959,190.08
开发支出27,864,900.2227,791,873.0627,635,945.3727,442,684.48
长期待摊费用30,408,318.7231,896,416.8929,998,078.9732,697,776.83
递延所得税资产224,119,716.13235,338,950.16207,864,992.45242,465,836.39
其他非流动资产2,512,443,441.863,115,559,353.023,405,777,581.383,189,671,664.84
非流动资产平衡项目0000
非流动资产合计6,089,097,203.466,693,760,287.16,835,377,216.566,619,611,473.32
资产平衡项目0000
资产总计16,638,920,951.3516,309,951,355.2916,101,606,403.1815,637,536,512.64
流动负债:
短期借款1,079,380,000899,730,000600,000,000900,000,000
应付票据及应付账款230,809,400.13217,162,847.72204,658,855.82210,358,797.65
其中:应付票据--6,907,33012,014,340
应付账款230,809,400.13217,162,847.72197,751,525.82198,344,457.65
合同负债16,962,615.4213,461,361.089,792,652.4919,198,473.99
应付职工薪酬477,374.4679,569.2514,696.99136,391.18
应交税费43,023,308.7433,559,564.5772,187,599.0735,666,046.96
其他应付款合计931,285,577.351,122,852,834.181,252,431,049.071,017,627,468.58
应付股利-93,931,367.5893,323,867.5893,323,867.58
一年内到期的非流动负债371,353.82371,353.82150,761,507.75150,761,507.75
其他流动负债66,066,116.3772,904,525293,699.54575,874.13
流动负债平衡项目0000
流动负债合计2,368,375,746.292,360,122,055.572,290,640,060.732,334,324,560.24
非流动负债:
租赁负债8,114,955.678,776,904.268,671,814.238,568,385.84
递延收益52,501,438.8754,181,97446,457,509.1348,085,544.26
递延所得税负债37,359,105.5640,144,438.0444,740,117.7440,818,062.08
非流动负债平衡项目0000
非流动负债合计97,975,500.1103,103,316.399,869,441.197,471,992.18
负债平衡项目0000
负债合计2,466,351,246.392,463,225,371.872,390,509,501.832,431,796,552.42
所有者权益(或股东权益):
实收资本(或股本)1,828,780,9261,828,780,9261,828,780,9261,828,780,926
资本公积1,430,209,795.991,429,993,625.131,446,836,942.141,483,172,018.21
减:库存股32,723,064.632,723,064.646,746,37846,746,378
盈余公积897,821,103.29897,821,103.29806,811,676.78806,811,676.78
未分配利润8,048,047,860.377,734,911,875.637,661,329,272.727,177,868,536.26
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计12,172,136,621.0511,858,784,465.4511,697,012,439.6411,249,886,779.25
少数股东权益2,000,433,083.911,987,941,517.972,014,084,461.711,955,853,180.97
股东权益平衡项目0000
股东权益合计14,172,569,704.9613,846,725,983.4213,711,096,901.3513,205,739,960.22
负债和股东权益合计16,638,920,951.3516,309,951,355.2916,101,606,403.1815,637,536,512.64
公告日期2025-04-282025-03-292024-10-302024-08-30
审计意见(境内)标准无保留意见
TOP↑